Schroeder Theodore R

CIK 00013786908 companiesFLORHAM PARK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001378690

Recent Transactions

50 trades

Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-05-19+24,122→ 45,122 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−875→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−875→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−1,400→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−20,500→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−11,100→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−2,125→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−450→ 0 total
Disposition to Issuer
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2026-01-07−550→ 0 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2025-06-18+11,100→ 11,100 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-04-16+21,000→ 21,000 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock (Right to Buy)
2025-04-16+35,000→ 35,000 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-12-17+20,500→ 20,500 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2023-06-22+42,500→ 42,500 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2023-01-29$1.50/sh−431→ 11,989 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2023-01-06$1.30/sh−11→ 12,420 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-12-31$1.89/sh−5→ 12,431 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-12-06$2.02/sh−9→ 12,436 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-11-30$2.25/sh−5→ 12,445 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-11-06$2.24/sh−10→ 12,450 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-10-31$2.54/sh−5→ 12,460 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-10-06$2.72/sh−9→ 12,465 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-09-30$2.08/sh−5→ 12,474 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-09-06$0.16/sh−225→ 311,977 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-08-31$0.16/sh−107→ 312,202 total
Exercise/Conversion
Nabriva Therapeutics plc
Restricted Stock Units
2022-08-11−119,900→ 0 total
Exercise/Conversion
Nabriva Therapeutics plc
Share Options
2022-08-11−239,800→ 0 total
Exercise/Conversion
Nabriva Therapeutics plc
Stock Appreciation Right
2022-08-11+239,800→ 239,800 total
Exercise/Conversion
Nabriva Therapeutics plc
Phantom Shares
2022-08-11+119,900→ 119,900 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-08-06$0.18/sh−225→ 312,309 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-07-31$0.18/sh−107→ 312,534 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-07-06$0.18/sh−225→ 312,641 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-06-30$0.18/sh−107→ 312,866 total
Award
Cidara Therapeutics, Inc.$CDTX
Stock Option (right to buy)
2022-06-22+28,000→ 28,000 total
Award
OTONOMY, INC.
Stock Option (right to buy)
2022-06-21+27,500→ 27,500 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-06-06$0.20/sh−225→ 312,973 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-05-31$0.21/sh−107→ 313,198 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-05-06$0.26/sh−225→ 313,305 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-04-30$0.31/sh−107→ 313,530 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-04-06$0.41/sh−219→ 313,637 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-03-31$0.42/sh−104→ 313,856 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-03-06$0.43/sh−263→ 313,960 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-02-28$0.45/sh−125→ 314,223 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-02-06$0.48/sh−263→ 314,348 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-01-31$0.48/sh−125→ 314,611 total
Tax Payment
Nabriva Therapeutics plc
Ordinary Shares
2022-01-29$0.45/sh−10,766→ 314,736 total

Companies

Recent Filings

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932

View on SEC.gov